Table 1(a).
Baseline characteristics of patients according to the pattern of VT induced (ARVC- Arryhthmogenic right ventricular cardiomyopathy, CAD- Coronary artery disease, CHD- Congenital heart disease, DCM-Dilated cardiomyopathy, EMF-Endomyocardial fibrosis, HCM- Hypertrophic cardiomyopathy, MVP- Mitral valve prolapsed, RCM- Restrictive cardiomyoapthy, SHD- Structural heart disease).
| INDUCIBLE (n = 79) |
NON INDUCIBLE (n = 90) |
p value |
|||
|---|---|---|---|---|---|
| INDUCIBLE MONOMORPHIC VT (n = 67) | SUSTAINED POLYMORPHIC VT (n = 12) | (INDUCIBLE VERSUS NON INDUCIBLE) | |||
| Demographics | |||||
| Gender | M = 59; F = 8 | M = 10; F = 2 | M = 73; F = 17 | ||
| Median age | 54 (Range 19–76 yrs) | 57.6(Range28-82 yrs) | 41.07 (17–78yrs) | ||
| Underlying SHD n (%) | |||||
| CAD | 44 (65.67%) | 5 (41.67%) | 30 (33.33%) | <0.0001 | |
| RHD | 2 (2.98%) | 0 | 5 (5.56%) | 0.454 | |
| DCM | 7 (10.44%) | 2 (16.67%) | 8 (8.89%) | 0.612 | |
| ARVD | 6 (8.95%) | 0 | 8 (8.89%) | 0.788 | |
| EMF | 0 | 1 (8.33%) | 4 (4.44%) | 0.372 | |
| MVP | 0 | 1 (8.33%) | 4 (4.44%) | 0.372 | |
| HCM | 4 (5.97%) | 3 (25%) | 14 (15.56%) | 0.244 | |
| CHD | 3 (4.47%) | 0 | 12 (13.33%) | 0.032 | |
| RCM | 1 (1.49%) | 0 | 0 | 0.467 | |
| SARCOID | 1 (1.49%) | 0 | 2 (2.22%) | 1.000 | |
| BAV | 0 | 0 | 2 (2.22%) | 0.499 | |
| MYOCARDITIS | 0 | 0 | 1 (1.11%) | 0.467 | |
| Noncompaction CMP | 0 | 0 | 1 (1.11%) | 0.467 | |
| Symptoms n (%) | |||||
| Syncope | 44 (65.67%) | 758.33%) | 59 (65.56%) | 1.000 | |
| Presyncope | 3 (4.47%) | 3 (25%) | 8 (8.89%) | 0.788 | |
| Palpitations | 20 (29.87%) | 2 (16.67%) | 16 (17.78%) | 1408 | |
| Dyspnea | 2 (3.98%) | 0 | 3 (3.33%) | 1.000 | |
| SC ARREST | 4 (5.97%) | 0 | 2 (2.22%) | 0.419 | |